Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT
Report from the Asian Myeloma Network
Japan Myeloma Network
Myeloma UK
Hot topics at IMW 2013 - interactive discussion
Challenging paradigms in multiple myeloma
Minimal residual disease
Consolidation and maintenance regimens in multiple myeloma
Myeloma in Asia
Multiple myeloma: transplant setting in the younger patient
Hot topics at IMW 2013
New assay predicts myeloma survival
Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma
Whole genome sequencing reveals underlying genetics of multiple myeloma
Myeloma bone disease: background and latest
Mutiple myeloma treatment in the non-transplant setting
New data in the diagnosis and prognosis of multiple myeloma
Relapse and retreatment of multiple myeloma